ASCO® 2024 Summary: "Gynecologic Oncology Updates"

2024 ASCO® Annual Meeting Insights Hub

R. Salani

Recent FDA Indications in Endometrial Cancers

Brian Slomovitz

ESMO 2024 Summary: dMMR Advanced/Recurrent Endometrial Cancer - Adva…

2024 ESMO Annual Meeting Insights Hub

M. Raza Mirza

ASCO® 2024 Summary: "Gynecological Cancers Highlights"

2024 ASCO® Annual Meeting Insights Hub

M. Raza Mirza

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

Year in Review 2024 - Endometrial Cancer

Mansoor Raza Mirza

ESMO 2024 Insights: Pembro or Placebo in Combination With Adjuvant C…

2024 ESMO Annual Meeting Insights Hub

B. Slomovitz

Gynecologic Oncology Updates: Expert Perspective on Key Trial Findin…

Yale Cancer Center

E. Ratner

Endometrial Cancer: The Current Treatment Landscape

Hope Cottrill

ASCO® 2024 Summary: "Timing of Debulking Surgery in Advanced Endomet…

2024 ASCO® Annual Meeting Insights Hub

A. Karam

SGO 2024 Endometrial Cancer Highlights

Insights from 2024 SGO Annual Meeting

P. Binder

Cancer Screening Molecular Tools

Fengting Yan

Durvalumab/C/T as 1L Treatment for dMMR Advanced Endometrial Cancer:…

Dana Chase

Precision Oncology in the Management of Endometrial Cancer

Miami Cancer Institute Precision Oncology Symposium

J. Diaz, B. Slomovitz

Efficacy and Safety of Sacituzumab Govitecan in Advanced/Metastatic …

Alessandro Santin

SGO 2024 Summary: "Key Updates in Endometrial Cancer"

Insights from 2024 SGO Annual Meeting

M. Raza Mirza

Molecular Subclassifications of Endometrial Cancer and Corresponding…

University of Miami Sylvester Comprehensive Cancer Center

A. Sinno

Antibody Drug Conjugates in Gynecologic Oncology: From Bench to Beds…

UCLA Health

G. Konecny

SGO 2024 Insights: "GOG-0258 - OS by Molecular Classification With a…

Insights from 2024 SGO Annual Meeting

A. Clements

Classification, Diagnosis and Treatment of Endometrial Cancer in 2024

Yale Cancer Center

P. Dottino